CIK 0001870144 · <br>Emerging growth company
Cardio Diagnostics Holdings, Inc.
Sign in to watch- Ticker
- CDIO
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870925574
- Phone
- 855-226-9991
- Business address
- 311 W. SUPERIOR STREET, SUITE 444, CHICAGO, IL, 60645
- Former names
- Mana Capital Acquisition Corp.
Securities
- CDIO Common stock Nasdaq
- CDIOW Warrant Nasdaq
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event New debt or obligation · Other events
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Regulation FD disclosure
- S-4/A Deal Registration Statement - Business Combination
- CORRESP Other Correspondence Between Filers and SEC Staff
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement
- UPLOAD Other SEC-generated Letter
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Regulation FD disclosure
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event New debt or obligation · Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- 10-Q Report Quarterly Report
- UPLOAD Other SEC-generated Letter
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
Page 13 of 15 · 296 filings